Summary of Study ST003245
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002015. The data can be accessed directly via it's Project DOI: 10.21228/M85238 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST003245 |
| Study Title | Exploration of Zeb1-dependent changes in the lipidome of MDA-MB-231 cells |
| Study Summary | Human breast cancer MDA-MB-231 wildtype (WT) cells and the stably transduced MDA-MB-231 shZeb1 (stable Zeb1 knockdown) and shCtrl cell lines (control cell line for the stable Zeb1 knockdown) (Spaderna et al. 2008, DOI: 10.1158/0008-5472.CAN-07-5682) were analyzed for their phospholipid profile by UPLC-MS/MS. Please note that one sample set was measured three times with the same sample-ID, but with different methods (PE, PC, PI), therefore each sub-class has their own raw-data file marked by their corresponding abbreviation (PE, PC, PI; e.g. "210514_MDA_ZEB1_PE_dil_1_10_std_1ul_JZ_PE_MRM_002.wiff", "210514_MDA_ZEB1_PC_dil_1_10_std_1ul_JZ_PC_MRM_002.wiff" or "210514_MDA_ZEB1_PC_dil_1_10_std_1ul_JZ_PC_MRM_002.wiff"). |
| Institute | University of Innsbruck |
| Department | Michael Popp Institute |
| Last Name | Koeberle |
| First Name | Andreas |
| Address | Mitterweg 24, Innsbruck, Tyrol, 6020, Austria |
| Andreas.Koeberle@uibk.ac.at | |
| Phone | +43 512 507 57903 |
| Submit Date | 2024-05-27 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | wiff |
| Analysis Type Detail | LC-MS |
| Release Date | 2024-07-05 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | local_sample_id | Sample source | Genotype |
|---|---|---|---|
| SA353432 | 220408_MDA shCtrl_1_10_PC_8 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353433 | 230309_shCTRL shZEB1_Rao_shCTRL_5 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353434 | 230309_shCTRL shZEB1_Rao_shCTRL_6 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353435 | 230309_shCTRL shZEB1_Rao_shCTRL_7 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353436 | 230309_shCTRL shZEB1_Rao_shCTRL_8 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353437 | 220408_MDA shZEB1_1_10_PE_7 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353438 | 220408_MDA shCtrl_1_10_PC_7 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353439 | 220408_MDA shCtrl_1_10_PC_6 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353440 | 220408_MDA shCtrl_1_10_PC_5 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353441 | 220408_MDA shZEB1_1_10_PE_8 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353442 | 220408_MDA shZEB1_1_10_PE_6 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353443 | 210514_MDA_ZEB1_n3_2h_sh-Ctrl_DMSO_22 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353444 | 210514_MDA_ZEB1_n2_2h_sh-Ctrl_DMSO_13 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353445 | 210514_MDA_ZEB1_n1_2h_sh-Ctrl_DMSO_4 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353446 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#4_3 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353447 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#4_2 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353448 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#4_1 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353449 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#1_3 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353450 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#1_2 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353451 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#1_1 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353452 | 220408_MDA shZEB1_1_10_PE_5 | Breast cancer cell line | control for Zeb1 stable knockdown |
| SA353405 | 210514_MDA_ZEB1_n3_2h_WT_DMSO_19 | Breast cancer cell line | Wild-type |
| SA353406 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__MDA_MB_231_WT_2 | Breast cancer cell line | Wild-type |
| SA353407 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__MDA_MB_231_WT_1 | Breast cancer cell line | Wild-type |
| SA353408 | 210514_MDA_ZEB1_n2_2h_WT_DMSO_10 | Breast cancer cell line | Wild-type |
| SA353409 | 210514_MDA_ZEB1_n1_2h_WT_DMSO_1 | Breast cancer cell line | Wild-type |
| SA353410 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__MDA_MB_231_WT_3 | Breast cancer cell line | Wild-type |
| SA353411 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#F10_2 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353412 | 220408_MDA shCtrl_1_10_PE_4 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353413 | 220408_MDA shCtrl_1_10_PE_3 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353414 | 220408_MDA shCtrl_1_10_PE_2 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353415 | 220408_MDA shCtrl_1_10_PE_1 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353416 | 220408_MDA shZEB1_1_10_PC_2 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353417 | 220408_MDA shZEB1_1_10_PC_3 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353418 | 210514_MDA_ZEB1_n3_2h_sh-ZEB1_DMSO_25 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353419 | 210514_MDA_ZEB1_n2_2h_sh-ZEB1_DMSO_16 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353420 | 210514_MDA_ZEB1_n1_2h_sh-ZEB1_DMSO_7 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353421 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#F10_3 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353422 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#F10_1 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353423 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#13_3 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353424 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#13_2 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353425 | 190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#13_1 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353426 | 220408_MDA shZEB1_1_10_PC_4 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353427 | 230309_shCTRL shZEB1_Rao_shZEB1_1 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353428 | 230309_shCTRL shZEB1_Rao_shZEB1_2 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353429 | 230309_shCTRL shZEB1_Rao_shZEB1_3 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353430 | 230309_shCTRL shZEB1_Rao_shZEB1_4 | Breast cancer cell line | Zeb1 stable knockdown |
| SA353431 | 220408_MDA shZEB1_1_10_PC_1 | Breast cancer cell line | Zeb1 stable knockdown |
| Showing results 1 to 48 of 48 |
